FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

LUDWIG DAVID F
2. Issuer Name and Ticker or Trading Symbol

BALCHEM CORP [ BCPC ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Vice President, Specialty & In
(Last)          (First)          (Middle)

52 SUNRISE PARK RD
3. Date of Earliest Transaction (MM/DD/YYYY)

8/29/2019
(Street)

NEW HAMPTON, NY 10958
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  8/29/2019    M    2062  A $21.39  21038  D   
Common Stock  8/29/2019    S    2062  D $90  18976  D   
Common Stock  8/30/2019    M    10688  A $21.39  29664  D   
Common Stock  8/30/2019    S    10688  D $90  18976  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option  $21.39  8/29/2019    M        2062   12/8/2011  12/8/2019  Common Stock  2062  $0  10688  D   
Stock Option  $21.39  8/30/2019    M        10688   12/8/2011  12/8/2019  Common Stock  10688  $0  0  D   

Explanation of Responses:

Remarks:
As reflected in this Form 4, Mr. Ludwig exercised 12,750 stock options. The options were scheduled to expire on December 8, 2019 and Mr. Ludwig is subject to the Company's blackout periods, which provide for limited windows of time in which he can transact in Company stock. Mr. Ludwig then sold 12,750 shares in the open market due to his desire to diversify his investment portfolio in connection with his pending retirement (reported on Form 8-K on August 2, 2019. As reflected in Column 5, Mr. Ludwig's holdings remain substantially in excess of his share ownership target under the Company's Policy Establishing Stock Ownership for Directors and Executive Officers following the reported transactions.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
LUDWIG DAVID F
52 SUNRISE PARK RD
NEW HAMPTON, NY 10958


Vice President, Specialty & In

Signatures
Mark Stach 8/30/2019
**Signature of Reporting Person Date


Balchem (NASDAQ:BCPC)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Balchem Charts.
Balchem (NASDAQ:BCPC)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Balchem Charts.

Balchem Corp News

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Balchem Corporation Reports First Quarter 2024 Financial Results
Friday 3 May 2024 (2 days ago) • GlobeNewswire Inc.
New York Jets Announce Multi-Year Partnership with VitaCholine®
Thursday 2 May 2024 (3 days ago) • GlobeNewswire Inc.
Balchem Corporation to Attend the BMO 19th Annual Global Farm to Market Conference on May 16, 2024
Wednesday 1 May 2024 (4 days ago) • GlobeNewswire Inc.
Balchem Corporation Releases 2023 Sustainability Report
Monday 22 April 2024 (2 weeks ago) • GlobeNewswire Inc.
Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on May 3, 2024
Friday 19 April 2024 (2 weeks ago) • GlobeNewswire Inc.
Form 144 - Report of proposed sale of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 144 - Report of proposed sale of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
Balchem Corporation to Participate at the BNP Paribas Exane 12th Consumer Ingredients Conference on March 14, 2024
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 144 - Report of proposed sale of securities
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 24 February 2024 (2 months ago) • Edgar (US Regulatory)